ATC Group: J01XX Other antibacterials

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J01XX in the ATC hierarchy

Level Code Title
1 J Antiinfectives for systemic use
2 J01 Antibacterials for systemic use
3 J01X Other antibacterials
4 J01XX Other antibacterials

Group J01XX contents

Code Title
J01XX01 Fosfomycin
J01XX02 Xibornol
J01XX03 Clofoctol
J01XX04 Spectinomycin
J01XX05 Methenamine
J01XX06 Mandelic acid
J01XX07 Nitroxoline
J01XX08 Linezolid
J01XX09 Daptomycin
J01XX10
J01XX11
J01XX12

Active ingredients in J01XX

Active Ingredient Description
Clofoctol
Daptomycin

Daptomycin is a cyclic lipopeptide natural product that is active against Gram positive bacteria only. The mechanism of action involves binding to bacterial membranes of both growing and stationary phase cells causing depolarisation and leading to a rapid inhibition of protein, DNA, and RNA synthesis.

Fosfomycin

Fosfomycin exerts a bactericidal effect on proliferating pathogens by preventing the enzymatic synthesis of the bacterial cell wall. Fosfomycin inhibits the first stage of intracellular bacterial cell wall synthesis by blocking peptidoglycan synthesis.

Lefamulin

Lefamulin is a pleuromutilin antibacterial agent. It inhibits bacterial protein synthesis by interacting with the A- and P- sites of the peptidyl transferase centre (PTC) in the central part of domain V of the 23S rRNA of the 50S ribosomal subunit, preventing correct positioning of the tRNA. Lefamulin is indicated for the treatment of community-acquired pneumonia (CAP) in adults.

Linezolid

Linezolid is a synthetic, antibacterial agent that belongs to a new class of antimicrobials, the oxazolidinones. It has in vitro activity against aerobic Gram-positive bacteria and anaerobic micro-organisms. Linezolid selectively inhibits bacterial protein synthesis via a unique mechanism of action.

Methenamine

Methenamine is a urinary antibacterial agent with a wide antibacterial spectrum covering both gram-positive and gram-negative organisms. Urinary antibacterial activity can be shown within 30 minutes of administration.

Nitroxoline
Spectinomycin

Spectinomycin is an inhibitor of protein synthesis in the bacterial cell; the site of action is the 30S ribosomal subunit. Spectinomycin is indicated in the treatment of acute gonorrheal urethritis and proctitis in the male and acute gonorrheal cervicitis and proctitis in the female when due to susceptible strains of Neisseria gonorrhoeae.

Tedizolid

Tedizolid is an oxazolidinone prodrug. The antibacterial activity of tedizolid is mediated by binding to the 50S subunit of the bacterial ribosome resulting in inhibition of protein synthesis. Tedizolid is primarily active against Gram-positive bacteria.

Related product monographs

Title Information Source Document Type  
CUBICIN Powder for concentrate for solution for injection or infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
FOMICYT Powder for solution for infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
HIPREX Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
KIRIN Powder for suspension for injection Υπουργείο Υγείας (CY) MPI, EU: SmPC
LINEZOLID Film-coated tablets Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
LINEZOLID Solution for infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
MONURIL Granules for oral solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
MONUROL Granules for oral solution FDA, National Drug Code (US) MPI, US: SPL/Old
SIVEXTRO Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC
SIVEXTRO Powder for concentrate for solution for infusion European Medicines Agency (EU) MPI, EU: SmPC
TRACTINFECT Powder for oral solution Health Products Regulatory Authority (ZA) MPI, Generic
XENLETA Solution for injection / Film-coated tablet FDA, National Drug Code (US) MPI, US: SPL/PLR
ZYVOX Solution for injection FDA, National Drug Code (US) MPI, US: SPL/PLR
ZYVOXID Tablet / Solution for Infusion / Granules for suspension Health Products Regulatory Authority (ZA) MPI, Generic